Clear.bio
Amsterdam
Investment thesis
Clear.bio develops technology-enabled solutions for type 2 diabetes management, combining personalized nutrition guidance with data-driven insights from continuous glucose monitoring. The company's approach focuses on addressing the root causes of type 2 diabetes rather than symptom management, enabling patients to achieve remission and improved health outcomes through behavioral change. The platform integrates scientific expertise in nutrition and metabolic health with digital tools to make personalized diabetes care accessible and scalable.
Source: firm website, verified Aug 6, 2026.
Frequently asked questions
- What sectors does Clear.bio focus on?
- Clear.bio focuses on Digital Health, Healthtech.
- Where is Clear.bio located?
- Clear.bio is headquartered in Amsterdam, NL.
Images
Co-investors · 1
Firms observed investing alongside Clear.bio, from public investor directories.
Similar investors
500 Global (formerly 500 Startups) is a venture capital firm that invests in startups worldwide and runs programs for founders and investors.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.